GGrantIndex
Sort

50,496 grants matching lung cancer

Clinical Trials Office

$386,061
Scott A Baker · University Of Minnesota · P30 · FY2011 · CA

Promoting tumor cell apoptosis by death ligands

$386,039
Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Ligand-mediated, vehicle-free delivery of small RNAs

$386,024
Andrea L Kasinski · Purdue University · R01 · FY2025 · CA

ATP-Dependent Chromatin Remodeling in Human Malignancy

$386,000
Gerald R. Crabtree · Stanford University · R01 · FY2025 · CA

Functional Analysis of Distinct and Co-existing Transcriptional Programs Regulating Tumor Dormancy

$385,985
Maria Sosa · Albert Einstein College Of Medicine · R01 · FY2024 · CA

Molecular mechanisms of lung disease in ataxia telangiectasia

$385,975
Joann M Sekiguchi · University Of Michigan At Ann Arbor · R01 · FY2012 · HL

Genetics and Environment in Adult Respiratory, Allergic and Cardiac disease

$385,972
Stephanie London · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES

Targeting the liver for immunotherapy in pancreatic cancer

$385,938
Gregory L Beatty · University Of Pennsylvania · R01 · FY2025 · CA

Targeting the liver for immunotherapy in pancreatic cancer

$385,938
Gregory L Beatty · University Of Pennsylvania · R01 · FY2022 · CA

Immunologic Mechanisms In Experimental Autoimmune Diseases Of The Nervous System

$385,933
Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS

Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1

$385,928
Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2022 · GM

Functional restoration through salivary progenitor label retaining cells

$385,928
Kirsten H Limesand · University Of Arizona · R01 · FY2015 · DE

Regulation Of Metabolism And Gene Expression By Iron-Sulfur Clusters - Resubmission - 1

$385,928
Richard Lewis Possemato · New York University School Of Medicine · R01 · FY2023 · GM

Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine

$385,924
Shay Soker · Wake Forest University Health Sciences · R33 · FY2018 · CA

Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine

$385,924
Shay Soker · Wake Forest University Health Sciences · R33 · FY2017 · CA

Dendritic Cell Biology and Therapy

$385,909
Olivera J Finn · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA

Development and Validation of a Microdissection Method to Advance Precision Medicine in the Clinical Setting

$385,890
Donald Johann · Univ Of Arkansas For Med Scis · R33 · FY2017 · CA

Development and Validation of a Microdissection Method to Advance Precision Medicine in the Clinical Setting

$385,890
Donald Johann · Univ Of Arkansas For Med Scis · R33 · FY2018 · CA

Modulation of the mTOR Pathway for Lung Cancer Treatment

$385,887
Fadlo Raja Khuri · Emory University · P01 · FY2010 · CA

Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease

$385,883
Sven-Eric Jordt · Yale University · R01 · FY2013 · HL

Function of PHD Domain Proteins in Chromatin Regulation

$385,876
Or P. Gozani · Stanford University · R01 · FY2020 · GM

ICCS in Lung Cancer: Evaluating Survival Benefits

$385,875
James F Cleary · University Of Wisconsin-Madison · P50 · FY2010 · CA

Endogenous Regulators of Inflammation in Periodontal Tissue Homeostasis

$385,839
Sinem Esra Sahingur · University Of Pennsylvania · R01 · FY2021 · DE

Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers

$385,834
James A Eastham · Sloan-Kettering Inst Can Research · U01 · FY2025 · CA

Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine

$385,820
Shay Soker · Wake Forest University Health Sciences · R33 · FY2016 · CA